Relation between serum ferritin and liver and heart MRI T2* in beta thalassaemia major patients;Relation entre la ferritine sérique et l'IRM hépatique et cardiaque pondérée en T2* chez des patients atteints de bÊta-thalassémie majeure

Eastern Mediterranean Health Journal

Volumn 19, Issue 8, 2013, Pages 727-732

  Azarkeivan, A ^a   Hashemieh, M ^b   Akhlaghpoor, S ^c   Shirkavand, A ^d   Yaseri, M ^d   Sheibani, K ^b  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DEFEROXAMINE; HEPATITIS C ANTIBODY; LIVER ENZYME;

ADULT; ARTICLE; BETA THALASSEMIA; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEART; HUMAN; IRON STORAGE; LIVER; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; THALASSEMIA MAJOR;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BETA-THALASSEMIA; FEMALE; FERRITINS; HEART; HEPATITIS C ANTIBODIES; HUMANS; IRAN; IRON; IRON OVERLOAD; LIVER; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MEDICAL AUDIT; MYOCARDIUM; YOUNG ADULT;

EID: 84883418115     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin, 2007, 31:251-256.
2. Hamed EA, El Melegy NT. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Italian Journal of Pediatrics, 2010, 36:39.
3. Economou M et al. Renal dysfunction in patients with betathalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematologica, 2010, 123:148-152.
4. Schrier SL, Angelucci E. New strategies in the treatment of the thalassemias. Annual Review of Medicine, 2005, 56:157-171.
5. Cohen AR et al. Thalassemia. Hematology (American Society of Hematology Education Program). Washington DC, American Society of Hematology, 2004:14-34.
6. Argyropoulou MI, Astrakas L. MRI evaluation of tissue iron burden in patients with beta-thalassaemia major. Pediatric Radiology, 2007, 37:1191-1200, quiz 1308-1309
7. Wood JC. Magnetic resonance imaging measurement of iron overload. Current Opinion in Hematology, 2007, 14:183-190.
8. St Pierre TG et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood, 2005, 105:855-861.
9. Kirk P et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. Journal of Magnetic Resonance Imaging, 2010, 32:315-319.
10. Tanner MA et al.; Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica, 2006, 91:1388-1391.
11. Kirk P et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation, 2009, 120:1961-1968.
12. Anderson LJ et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. European Heart Journal, 2001, 22:2171-2179.
13. Anderson LJ. Assessment of iron overload with T2* magnetic resonance imaging. Progress in Cardiovascular Diseases, 2011, 54:287-294.
14. Aessopos A, Berdoukas V, Tsironi M. The heart in transfusion dependent homozygous thalassaemia today-prediction, prevention and management. European Journal of Haematology, 2008, 80:93-106.
15. Roghi A et al. Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study. Annals of Hematology, 2010, 89:585-589.
16. Anderson LJ et al. Development of thalassaemic iron overload cardiomyopathy despite low liver iron levels and meticulous compliance to desferrioxamine. Acta Haematologica, 2006, 115:106-108.
17. Hashemieh M et al. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients. Archives of Iranian Medicine, 2012, 15:91-94.
18. Deborah Chirnomas S et al. Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias. American Journal of Hematology, 2008, 83:781-783.
19. Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World Journal of Gastroenterology, 2010, 16:1587-1597.
20. Westwood M et al. A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. Journal of Magnetic Resonance Imaging, 2003, 18(1):33-39.
21. Ooi GC et al. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients. British Journal of Haematology, 2004, 124:385-390.
22. Voskaridou E et al. Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia. Kidney International, 2006, 69:2037-2042.
23. Perifanis V, et al. comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. International Journal of Hematology, 2007, 86:385-389.
24. Mazza P et al. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica, 1995, 80:398-404.
25. Zamani F et al. T2* magnetic resonance imaging of the liver in thalassemic patients in Iran. World Journal of Gastroenterology, 2011, 17:522-525.
26. Worwood M et al. Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. British Journal of Haematology, 1980, 46:409-416.
27. Leung AW et al. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatric Blood & Cancer, 2009, 53:1054-1059.
28. Di Tucci AA et al. Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica, 2008, 93:1385-1388.
29. Fragasso A et al. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias. European Journal of Internal Medicine, 2011, 22:62-65.
30. Koliakos G et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in beta-thalassaemia. Clinical and Laboratory Haematology, 2003, 25:105-109.
31. Papakonstantinou O et al. Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. Journal of Pediatric Hematology/Oncology, 1999, 21:142-148
32. Christoforidis A et al. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients. Journal of Pediatric Hematology/Oncology, 2006, 28:311-315.